APCEDENÂ , Dendritic cell based Immunotherapy for the treatment of cancer.
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Primary outcome(s): 1. Overall Survival 2. Evaluation of objective response through Immune related Response Criteria (irRC): measure of PD; PR and SD. 3. Immune response as assessed through Treg population and serum IFN-γ levels 4. Monitor treatment emergent adverse events. Timepoint: 1. Overall Survival 2. Evaluation of objective response through Immune related Response Criteria (irRC): measure of PD; PR and SD. 3. Immune response as assessed through Treg population and serum IFN-γ levels 4. Monitor treatment emergent adverse events.
创建时间：
2017-12-15
